These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Effects of bryostatin 1, a novel anticancer agent, on intestinal transport and barrier function: role of protein kinase C. Farokhzad OC; Mun EC; Sicklick JK; Smith JA; Matthews JB Surgery; 1998 Aug; 124(2):380-6; discussion 386-7. PubMed ID: 9706162 [TBL] [Abstract][Full Text] [Related]
31. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1. Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857 [TBL] [Abstract][Full Text] [Related]
32. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation. Szallasi Z; Denning MF; Smith CB; Dlugosz AA; Yuspa SH; Pettit GR; Blumberg PM Mol Pharmacol; 1994 Nov; 46(5):840-50. PubMed ID: 7969070 [TBL] [Abstract][Full Text] [Related]
33. Structural insights into the calmodulin-Munc13 interaction obtained by cross-linking and mass spectrometry. Dimova K; Kalkhof S; Pottratz I; Ihling C; Rodriguez-Castaneda F; Liepold T; Griesinger C; Brose N; Sinz A; Jahn O Biochemistry; 2009 Jun; 48(25):5908-21. PubMed ID: 19492809 [TBL] [Abstract][Full Text] [Related]
34. The transient increase of tight junction permeability induced by bryostatin 1 correlates with rapid downregulation of protein kinase C-alpha. Clarke H; Ginanni N; Laughlin KV; Smith JB; Pettit GR; Mullin JM Exp Cell Res; 2000 Nov; 261(1):239-49. PubMed ID: 11082294 [TBL] [Abstract][Full Text] [Related]
35. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells. Jalava AM; Heikkilä J; Akerlind G; Pettit GR; Akerman KE Cancer Res; 1990 Jun; 50(11):3422-8. PubMed ID: 2334938 [TBL] [Abstract][Full Text] [Related]
36. Munc13-1 is required for the sustained release of insulin from pancreatic beta cells. Kang L; He Z; Xu P; Fan J; Betz A; Brose N; Xu T Cell Metab; 2006 Jun; 3(6):463-8. PubMed ID: 16697276 [TBL] [Abstract][Full Text] [Related]
37. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines. Kennedy MJ; Prestigiacomo LJ; Tyler G; May WS; Davidson NE Cancer Res; 1992 Mar; 52(5):1278-83. PubMed ID: 1737390 [TBL] [Abstract][Full Text] [Related]
38. Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1. Basu A; Lazo JS Cancer Res; 1992 Jun; 52(11):3119-24. PubMed ID: 1591725 [TBL] [Abstract][Full Text] [Related]
39. Evidence against roles for phorbol binding protein Munc13-1, ADAM adaptor Eve-1, or vesicle trafficking phosphoproteins Munc18 or NSF as phospho-state-sensitive modulators of phorbol/PKC-activated Alzheimer APP ectodomain shedding. Ikin AF; Causevic M; Pedrini S; Benson LS; Buxbaum JD; Suzuki T; Lovestone S; Higashiyama S; Mustelin T; Burgoyne RD; Gandy S Mol Neurodegener; 2007 Dec; 2():23. PubMed ID: 18067682 [TBL] [Abstract][Full Text] [Related]
40. Two protein kinase C activators, bryostatin-1 and phorbol-12-myristate-13-acetate, have different effects on haemopoietic cell proliferation and differentiation. Ng SB; Guy GR Cell Signal; 1992 Jul; 4(4):405-16. PubMed ID: 1419483 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]